Bilobol inhibits the lipopolysaccharide-induced expression and distribution of RhoA in HepG2 human hepatocellular carcinoma cells

Oncology Letters

Volumn 10, Issue 2, 2015, Pages 962-966

  Xu, Jin ^a   Li, Yueying ^a   Yang, Xiaoming ^a   Liu, Yali ^a   Chen, Yongchang ^a   Chen, Min ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Bilobol; HepG2 cells; Lipopolysaccharide; RhoA

Indexed keywords

BILOBOL; CHINESE DRUG; CYTOPLASM PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PACLITAXEL; RHO ASSOCIATED PROTEIN KINASE 2; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPG2 CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LIPOPOLYSACCHARIDE-INDUCED AIRWAY INFLAMMATION; LIVER CELL CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHO ASSOCIATED PROTEIN KINASE SIGNALING; SIGNAL TRANSDUCTION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84931309371     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3276     Document Type: Article

References (29)

1. Farazi PA and DePinho RA: Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer 6: 674-687, 2006.
2. Forner A, Llovet JM and Bruix J: Hepatocellular carcinoma. Lancet 379: 1245-1255, 2012.
3. Hall A: The cellular functions of small GTP-binding proteins. Science 249: 635-640, 1990.
4. Li Y, Chen Y, Tao Y, Xu J and Chen M: RhoA protein is generally distributed in the nuclei of cancer cells. Oncol Rep 24: 1005-1009, 2010.
5. Li Y, Chen Y and Xu J: Factors influencing RhoA protein distribution in the nucleus. Mol Med Rep 4: 1115-1119, 2011.
6. Dubash AD, Guilluy C, Srougi MC, Boulter E, Burridge K and García-Mata R: The small GTPase RhoA localizes to the nucleus and is activated by Net1 and DNA damage signals. PLoS One 6: e17380, 2011.
7. Guilluy C, Dubash AD and García-Mata R: Analysis of RhoA and Rho GEF activity in whole cells and the cell nucleus. Nat Protoc 6: 2050-2060, 2011.
8. Wang Y, Tu Q, Yan W, et al: CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway. Biochem Biophys Res Commun 456: 373-379, 2015.
9. MacMicking J, Xie QW and Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350, 1997.
10. Knaus UG: Rho GTPase signaling in inflammation and transformation. Immunol Res 21: 103-109, 2000.
11. Wu M, Wu ZF, Rosenthal DT, Rhee EM and Merajver SD: Characterization of the roles of RHOC and RHOA GTPases in invasion, motility and matrix adhesion in inflammatory and aggressive breast cancers. Cancer 116 (Suppl): S2768-S2782, 2010.
12. Hori T, Ridge RW, Tulecke W, Del Tredici P, Tremouillaux-Guiller J and Tobe H (eds): Ginkgo biloba - A Global Treasure. From Biology to Medicine. 1st edition n. Springer, Tokyo, 1997.
13. Brondino N, De Silvestri A, Re S, Lanati N, Thiemann P, Verna A, Emanuele E and Politi P: A systematic review and meta-analysis of Ginkgo biloba in neuropsychiatric disorders: From ancient tradition to modern-day medicine. Evid Based Complement Alternat Med 2013: 915691, 2013.
14. von Boetticher A: Ginkgo biloba extract in the treatment of tinnitus: A systematic review. Neuropsychiatr Dis Treat 7: 441-447, 2011.
15. Wu Y, He L, Zhang L, Chen J, Yi Z, Zhang J, Liu M and Pang X: Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway. J Pharmacol Exp Ther 339: 403-411, 2011.
16. Park YJ, Kim MJ, Kim HR, Yi MS, Chung KH and Oh SM: Chemopreventive effects of Ginkgo biloba extract in estrogen-negative human breast cancer cells. Arch Pharm Res 36: 102-108, 2013.
17. Yang XM, Wang YF, Li YY, and Ma HL: Thermal stability of ginkgolic acids from Ginkgo biloba and the effects of ginkgol C17:1 on the apoptosis and migration of SMMC7721 cells. Fitoterapia 98: 66-76, 2014.
18. Jaggy H, and Koch E: Chemistry and biology of alkylphenols from Ginkgo biloba L. Pharmazie 52: 735-738, 1997.
19. Liu ZH and Zeng S: Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes. Toxicol Lett 187: 131-136, 2009.
20. Zhou C, Li X, Du W, Feng Y, Kong X, Li Y, Xiao L and Zhang P: Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy 56: 393-402, 2010.
21. Sotiropoulos A, Gineitis D, Copeland J and Treisman R: Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98: 159-169, 1999.
22. Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y and Yoshida K: Overexpression of RhoA, Rac1 and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 10: 4799-4805, 2004.
23. Price LS and Collard JG: Regulation of the cytoskeleton by Rho-family GTPases: Implications for tumour cell invasion. Semin Cancer Biol 11: 167-173, 2001.
24. Narumiya S: The small GTPase Rho: Cellular functions and signal transduction. J Biochem 120: 215-228, 1996.
25. Kennedy DO and Wightman EL: Herbal extracts and phytochemicals: Plant secondary metabolites and the enhancement of human brain function. Adv Nutr 2: 32-50, 2011.
26. Sukumari-Ramesh S, Singh N, Jensen MA, Dhandapani KM and Vender JR: Anacardic acid induces caspase-independent apoptosis and radiosensitizes pituitary adenoma cells. J Neurosurg 114: 1681-1690, 2011.
27. Lee CY, Yang JJ, Lee SS, Chen CJ, Huang YC, Huang KH and Kuan YH: Protective effect of Ginkgo biloba leaves extract, EGb761, on endotoxin-induced acute lung injury via a JNK-and Akt-dependent NFκB pathway. J Agric Food Chem 62: 6337-6344, 2014.
28. Goldie M and Dolan S: Bilobalide, a unique constituent of Ginkgo biloba, inhibits inflammatory pain in rats. Behav Pharmacol 24: 298-306, 2013.
29. Wettschureck N and Offermanns S: Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med Berl 80: 629-638, 2002.